DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹10,558 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹13,977 Cr |
| Mar2024 | ₹12,559 Cr |
| Mar2023 | ₹11,812 Cr |
| Mar2022 | ₹10,558 Cr |
| Mar2021 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,977 Cr | 11.29 | |
| Mar2024 | ₹12,559 Cr | 6.32 | |
| Mar2023 | ₹11,812 Cr | 11.88 | |
| Mar2022 | ₹10,558 Cr | 35.73 | |
| Mar2021 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,434.1 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -1.3% | -1.8% | -19.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.6% |
-6.8% |
1.5% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses